Brain Hemorrhage Market, by Drug Type (Anti-hypertensive Drugs, Anti-convulsants Drugs, Hyperosmostic Drugs, and Others (others include Anti-epileptic Drugs, Anti-pyretic Drugs, etc.)), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and

Brain Hemorrhage Market, by Drug Type (Anti-hypertensive Drugs, Anti-convulsants Drugs, Hyperosmostic Drugs, and Others (others include Anti-epileptic Drugs, Anti-pyretic Drugs, etc.)), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Brain hemorrhage is a medical emergency condition wherein blood vessel ruptures and causes bleeding inside the brain. This bleeding can also occur between the brain and the membranes covering the brain, between the skull and the covering of the brain or between the membrane layers covering the brain. The blood from the ruptured blood vessel irritates the surrounding tissues of brain and causes swelling, a condition known as cerebral edema. The blood from ruptured blood vessel starts pooling into a mass inside the brain and this mass is called a hematoma. Hematoma starts building pressure on the tissues of the brain, thus reducing vital blood flow to the brain and causing brain cells to die. Brain hemorrhage is identified as a type of stroke and requires immediate treatment and care with the help of medication or brain surgery. Some of the risk factors associated with occurrence of brain hemorrhage include brain trauma, brain tumor, weak blood vessels, liver drug, hypertension, excessive smoking, hypocholesterolemia, excessive alcohol consumption drugs, and online Pharmacies.
Market Dynamics
The increasing incidence of brain hemorrhage and head injury, rising research and development activities for the development of novel therapeutics for the treatment of brain hemorrhage, and increasing adoption of inorganic growth strategies such as acquisitions and collaborations by key players operating in the market, are the major factors that are expected to drive growth of the global brain hemorrhage market over the forecast period.
For instance, according to data provided by the Centers for Disease Control and Prevention it is estimated that around 61,000 people died due to traumatic brain injury in the U.S. in 2018, which indicates that nearly 166 deaths were caused due to traumatic brain injury every day in the U.S. in 2018, and this number is expected to increase in the near future.
Key features of the study:
This report provides in-depth analysis of the global brain hemorrhage market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global brain hemorrhage market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Baxter, Oxurion NV, Pfizer, Inc., F. Hoffmann-La Roche Ltd., Boehringer Ingelheim, Novartis AG, Bayer AG, Abbott, Bristol-Myers Squibb, Johnson and Johnson, Neurotech Pharmaceuticals, Inc., Siemens Healthcare GmbH, Novo Nordisk A/S, H. Lundbeck A/S, and Ligand Pharmaceuticals Incorporated
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global brain hemorrhage market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global brain hemorrhage market
Detailed Segmentation:
Global Brain Hemorrhage Market, By Drug Type:
Anti-hypertensive Drugs
Anti-convulsants Drugs
Hyperosmotic Drugs
Others (others include Anti-epileptic Drugs, Anti-pyretic Drugs, etc.)
Global Brain Hemorrhage Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Brain Hemorrhage Market, By Region:
North America
By Drug Type
Anti-hypertensive Drugs
Anti-convulsants Drugs
Hyperosmotic Drugs
Others (others include Anti-epileptic Drugs, Anti-pyretic Drugs, etc.)
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country
U.S.
Canada
Latin America
By Drug Type
Anti-hypertensive Drugs
Anti-convulsants Drugs
Hyperosmotic Drugs
Others (others include Anti-epileptic Drugs, Anti-pyretic Drugs, etc.)
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Drug Type
Anti-hypertensive Drugs
Anti-convulsants Drugs
Hyperosmotic Drugs
Others (others include Anti-epileptic Drugs, Anti-pyretic Drugs, etc.)
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Drug Type
Anti-hypertensive Drugs
Anti-convulsants Drugs
Hyperosmotic Drugs
Others (others include Anti-epileptic Drugs, Anti-pyretic Drugs, etc.)
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Drug Type
Anti-hypertensive Drugs
Anti-convulsants Drugs
Hyperosmotic Drugs
Others (others include Anti-epileptic Drugs, Anti-pyretic Drugs, etc.)
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country
GCC
Israel
Rest of Middle East
Africa
By Drug Type
Anti-hypertensive Drugs
Anti-convulsants Drugs
Hyperosmotic Drugs
Others (others include Anti-epileptic Drugs, Anti-pyretic Drugs, etc.)
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country/Region
South Africa
Central Africa
North Africa
Company Profiles
Baxter*
Company Overview
Material Portfolio
Financial Performance
Key Highlights
Market Strategies
Oxurion NV
Pfizer, Inc.
F. Hoffmann-La Roche Ltd.
Boehringer Ingelheim
Novartis AG
Bayer AG
Abbott
Bristol-Myers Squibb
Johnson and Johnson
Neurotech Pharmaceuticals, Inc.
Siemens Healthcare GmbH
Novo Nordisk A/S
H. Lundbeck A/S
Ligand Pharmaceuticals Incorporated
“*” marked represents similar segmentation in other categories in the respective section.